Proximity Systems Announces UV-Cube

May 28, 2020

Proximity Systems, Inc., a leading provider in innovative health care furniture and technology, announced UV-Cube, a new product in their lineup of UV-C disinfection devices. Designed to disable pathogens by breaking the DNA sequence and rendering them unable to reproduce and spread, UV-Cube provides automated, chemical-free disinfection.

In laboratory testing performed at ResInnova Labs in March 2020, UV-Cube eliminated 99.9% of Methicillin-resistant Staphylococcus aureus (MRSA) after one minute and 99.999% of Methicillin-resistant Staphylococcus aureus (MRSA) after two minutes or more, reinforcing the efficacy of the unit’s ability to reduce harmful pathogens on high touch objects.

“As more employers look to UV-C disinfection to keep employees, customers and patients healthy and safe, we felt it was time to launch a new product that supported these efforts across all industries,” said Jeremy Goza, Proximity Systems’ CEO. “UV-Cube is the ideal size for handheld equipment and devices, including phones, tablets, remote controls, keys, point of sale electronics and so on. Leveraging Proximity’s UV-CLEAN technology, UV-Cube consistently cleans high touch items that otherwise act as reservoirs for harmful pathogens.”

UV-Cube has a sleek, stylish design at 11.9″ x 10.6″ x 6″ and features an internal rack for a 360-degree active cleaning area. 40 UV-C LED bulbs are activated during any of the three cleaning cycle modes: UV-CLEAN, UV-CLEAN & Dry and UV-CLEAN & Store. The cycles provide users options depending on their specific needs and the type of items being disinfected.

Proximity Systems Clinical Scientist, Steve Reinecke, explained UV-Cube offers a convenient area to place items for quick, yet effective ultraviolet disinfection.

“The reality is that germs do not discriminate based on industry. While disinfection is a primary focus in healthcare, our new heightened awareness around the need for disinfection of high touch public objects makes UV-Cube a necessary device to deal with the deadly pathogens found on these,” said Reinecke. “UV-Cube will not only help organizations keep employees safe and healthy, but it will provide peace of mind to employees and customers alike.”

Because UV-Cube does the disinfection work for you, its use can be applied to a variety of environments, from retail and hospitality to industrial and healthcare. Simply place items on the internal rack, select a cleaning cycle and either retrieve the items once disinfected or leave them in the UV-Cube on the Store cycle.

With UV-Cube by Proximity, users get a means of automatic self-disinfection that will set up a strong line of defense against the spread of infectious microorganisms on high-touch objects. Gain the upper hand in the battle against germs.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”